UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 9, 2016
Accession Number: 0001193125-16-759034
Submission Type: POS AM
CIK: 0001311596
Company Name: Tobira Therapeutics, Inc.
File Number: 333-204710